William B. O'Connor

2016

In 2016, William B. O'Connor earned a total compensation of $1.7M as Chief Financial Officer at Medicines, a 57% increase compared to previous year.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$287,203
Option Awards$552,100
Salary$465,000
Stock Awards$240,003
Other$11,164
Total$1,655,470

O'Connor received $552.1K in option awards, accounting for 33% of the total pay in 2016.

O'Connor also received $100K in bonus, $287.2K in non-equity incentive plan, $465K in salary, $240K in stock awards and $11.2K in other compensation.

Rankings

In 2016, William B. O'Connor's compensation ranked 5,787th out of 14,075 executives tracked by ExecPay. In other words, O'Connor earned more than 58.9% of executives.

ClassificationRankingPercentile
All
5,787
out of 14,075
59th
Division
Manufacturing
2,099
out of 5,486
62nd
Major group
Chemicals And Allied Products
682
out of 1,900
64th
Industry group
Drugs
511
out of 1,543
67th
Industry
Pharmaceutical Preparations
406
out of 1,173
65th
Source: SEC filing on April 26, 2017.

O'Connor's colleagues

We found four more compensation records of executives who worked with William B. O'Connor at Medicines in 2016.

2016

Clive Meanwell

Medicines

Chief Executive Officer

2016

Stuart Kingsley

Medicines

Chief Operating Officer

2016

Christopher Cox

Medicines

Chief Corporate Development Officer

2016

Stephen Rodin

Medicines

General Counsel

You may also like